Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Mirabella Eclano

3 clinical trials in Mirabella Eclano, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Mirabella Eclano at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Mirabella Eclano

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Mirabella Eclano

What the registry says about research in the country

01 Colorectal Cancer Research

Investigating advanced treatment approaches for metastatic colorectal cancer, with a focus on targeted therapies and their effectiveness in different treatment lines.

  • Treatment continuation strategies
  • Molecular-selected patient populations
  • Response rate evaluation

Studies include assessment of cetuximab treatment beyond first-line progression, utilizing external radiological evaluation for unbiased results.

02 Targeted Therapy Innovation

Evaluating different administration approaches of Panitumumab plus FOLFIRI in first-line treatment scenarios for specific colorectal cancer subtypes.

  • Intermittent vs continuous treatment
  • Safety and tolerability assessment
  • Quality of life impacts

Research includes comprehensive biomarker analysis to monitor treatment efficacy and resistance patterns in both tissue and blood samples.

03 Precision Medicine Applications

Focusing on RAS/B-RAF wild-type colorectal cancer, examining specialized treatment protocols for left-sided tumors.

  • Molecular profiling
  • Treatment optimization
  • Biomarker exploration

Studies aim to determine optimal treatment strategies for specific patient subgroups based on molecular characteristics.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.